Response to the Letter to the Editor by Koneswarakantha and Ménard Silke JanitzaMadhurima MajumderHermann Kulmann Letter to the Editor 11 March 2022 Pages: 379 - 380
Correction to: Response to the Letter to the Editor by Koneswarakantha and Ménard Silke JanitzaMadhurima MajumderHermann Kulmann Correction 21 March 2022 Pages: 381 - 381
Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions Andreea MolnarStephanie LauCharles H. Hennekens Commentary 11 February 2022 Pages: 382 - 385
Solution Oligonucleotide APIs: Regulatory Considerations Christian WetterChris ChorleyJanine Tom Review Open access 08 February 2022 Pages: 386 - 393
Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies Bill ByromCeleste A. ElashCindy Howry Review Open access 10 February 2022 Pages: 394 - 404
The Medical Information Scientific Process: Define, Research, Evaluate, Synthesize, and Share (DRESS) Dominick AlbanoFarah PraggaEvelyn R. Hermes-DeSantis Analytical Report Open access 03 March 2022 Pages: 405 - 414
Risk-Based Monitoring in Clinical Trials: Increased Adoption Throughout 2020 Nicole StansburyBrian BarnesAnina Adelfio Analytical Report Open access 02 March 2022 Pages: 415 - 422
Integrative Analysis of Randomized Clinical Trial and Observational Study Data to Inform Post-marketing Safety Decision-Making Li-An LinYafei ZhangWilliam Wang Analytical Report 09 February 2022 Pages: 423 - 432
Statistical Modeling for Quality Risk Assessment of Clinical Trials: Follow-Up at the Era of Remote Auditing Björn KoneswarakanthaTimothé Ménard Analytical Report 09 March 2022 Pages: 433 - 441
Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically Sarah GordonJennifer Cragerthe Electronic Patient-Reported (ePRO) Consortium, PRO Consortium Analytical Report Open access 01 March 2022 Pages: 442 - 453
Memory-Assisted Global Impression of Change (MAGIC) Linda S. DealDavid A. AndraeChristopher J. Evans Original Research 22 February 2022 Pages: 454 - 463
Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey Rui HuangHuiying RaoLai Wei Original Research 16 February 2022 Pages: 464 - 473
Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases Helle ChristiansenSteffen ThirstrupChristine Erikstrup Hallgreen Original Research Open access 07 February 2022 Pages: 474 - 482
Enhancing Patient Care II: The Clinical Impact of Medical Information Services Leena JindiaSharone KeaneEvelyn R. Hermes-DeSantis Original Research Open access 15 March 2022 Pages: 483 - 491
The Predictive Individual Effect for Survival Data Beat NeuenschwanderSatrajit RoychoudhuryEmmanuel Zuber Original Research 16 March 2022 Pages: 492 - 500
Application of Meta-analysis to Evaluate Relationships Among ARIA-E Rate, Amyloid Reduction Rate, and Clinical Cognitive Response in Amyloid Therapeutic Clinical Trials for Early Alzheimer’s Disease Deli WangElaine Kearney KowalewskiGary Koch Original Research 23 March 2022 Pages: 501 - 516
Optimal Sample Size for Use in Neonatal Pharmacokinetic Studies Bo-Hao TangBu-Fan YaoWei Zhao Original Research 30 January 2022 Pages: 517 - 522
Potential Future Drug Development Lag in Japan Based on an Analysis of Multiregional Clinical Trials in the US, Europe, and East Asia Atsushi NoguchiHideki HanaokaYoshiaki Uyama Original Research 18 February 2022 Pages: 523 - 529